IMMD Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

IMMD General Information

Description

Developer of a leading-edge rational drug design technology intended to identify drug seeds. The company's platform uses rational drug design technology to perform virtual screening to select and optimize the seeds by minimizing syntheses strategically based on estimated docking mode to the target, enabling researchers to find new drug targets and improve the efficiency of life science research.

Contact Information

Website
www.immd.co.jp
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Room 501, Inageya Building
  • 2-37-6 Hongo, Bunkyo-ku
  • Tokyo, 113-0033
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Room 501, Inageya Building
  • 2-37-6 Hongo, Bunkyo-ku
  • Tokyo, 113-0033
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IMMD Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 06-Jul-2026 Completed Out of Business
3. Secondary Transaction - Private Completed Generating Revenue
2. Later Stage VC 01-Mar-2017 Completed Generating Revenue
1. Seed Round 01-Oct-2010 Completed Startup
To view IMMD’s complete valuation and funding history, request access »

IMMD Patents

  • 64

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

IMMD Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2011043456-A1 Halogenated alkylsulfonamide derivative Inactive 09-Oct-2009
JP-6041396-B2 Pai-1 inhibitor Inactive 11-Apr-2008
JP-WO2009125606-A1 Pai-1 inhibitor Pending 11-Apr-2008
US-20090239868-A1 Inhibitor of pai-1 production Inactive 23-Oct-2007
JP-5470046-B2 Pai-1 production inhibitor Inactive 23-Oct-2007 C07D295/20
To view IMMD’s complete patent history, request access »

IMMD Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

IMMD FAQs

  • When was IMMD founded?

    IMMD was founded in 1995.

  • Where is IMMD headquartered?

    IMMD is headquartered in Tokyo, Japan.

  • What is the size of IMMD?

    IMMD has 6 total employees.

  • What industry is IMMD in?

    IMMD’s primary industry is Drug Discovery.

  • Is IMMD a private or public company?

    IMMD is a Private company.

  • What is IMMD’s current revenue?

    The current revenue for IMMD is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process